Literature DB >> 18029158

Dosimetric comparison of conventional radiograph- and three-dimensional computed tomography-based planning using dose volume indices for partial breast intraoperative implants.

S D Sharma1, A Budrukkar, R R Upreti, A Munshi, R Jalali, D D Deshpande.   

Abstract

AIMS: The dosimetric outcomes of radiograph- and computed tomography-based plans generated with various optimisation strategies were compared using dose volume indices for partial breast intraoperative implants.
MATERIALS AND METHODS: Eighteen patients with early stage breast cancer underwent conventional orthogonal radiograph and computed tomography to generate dosimetric data. Catheter reconstruction and delineation of the lumpectomy cavity, the planning target volume (PTV) and the ipsilateral breast were carried out on computed tomography images. For each patient, geometrically optimised plans (P(xray) and P(CT)) were generated using the active loading length based on the PTV defined from radiographs (PTV(xray)) and computed tomography (PTV(CT)). The plan P(CT) was further optimised graphically and yielded P(graphical). Plans were compared using the coverage index (CI), the external volume index (EI), the dose homogeneity index (DHI), the overdose volume index (OI) and the conformal index (COIN).
RESULTS: The mean CI of the lumpectomy cavity estimated from P(xray), P(CT) and P(graphical) was 0.80, 0.82 and 0.92, respectively. The corresponding values for PTV(CT) were 0.69, 0.71 and 0.85. P(graphical) showed an increase in CI by 23 and 19% with respect to P(xray) and P(CT) (P<0.001 in all) with a decrease in DHI from 0.81 to 0.71 (P<0.001) and increase in OI from 0.041 to 0.087 (P<0.001). The EI was highest in P(xray) (mean 44 cm(3)) as compared with 25 cm(3) in P(CT) and 30 cm(3) in P(graphical). A significant improvement in COIN was observed in P(graphical) (mean 0.68) compared with P(xray) (0.48) and P(CT) (0.58) (P<0.001).
CONCLUSIONS: Objective dosimetric evaluation on three-dimensional computed tomography confirms its superiority over conventional two-dimensional radiograph-based planning in terms of a reduction in normal breast irradiated with the prescription dose and improvement in conformity. Interactive graphical optimisation based on the target volume in computed tomography further improves conformity with a reduction in dose homogeneity. The use of dose volume indices allows the comparison of different plans and can be used as a tool to correlate dosimetric with clinical outcome.

Entities:  

Mesh:

Year:  2007        PMID: 18029158     DOI: 10.1016/j.clon.2007.09.006

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

Review 1.  Breast cancer: An overview of published Indian data.

Authors:  Bharath Rangarajan; Tanuja Shet; Tabassum Wadasadawala; Nita S Nair; R Madhu Sairam; Sachin S Hingmire; Jyoti Bajpai
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep

2.  Interobserver variations of target volume delineation and its impact on irradiated volume in accelerated partial breast irradiation with intraoperative interstitial breast implant.

Authors:  Ritu Raj Upreti; Ashwini Budrukkar; Tabassum Wadasadawala; Shagun Misra; Lavanya Gurram; Rima Pathak; Deepak D Deshpande
Journal:  J Contemp Brachytherapy       Date:  2017-02-14

3.  Multi-catheter interstitial brachytherapy for partial breast irradiation: an audit of implant quality based on dosimetric evaluation comparing intra-operative versus post-operative placement.

Authors:  Lavanya Gurram; Tabassum Wadasadawala; Kishor Joshi; Reena Phurailatpam; Siji Paul; Rajiv Sarin
Journal:  J Contemp Brachytherapy       Date:  2016-04-14

4.  Coverage with dosimetric concordance index (CDCI): a tool for evaluating dosimetric impact of inter-observer target variability in brachytherapy.

Authors:  Ritu Raj Upreti; Ashwini Budrukkar; Udita Upreti; Tabassum Wadasadawala; Rima Pathak; Shagun Misra; Lavanya Gurrum; Rajesh A Kinhikar; Deepak D Deshpande
Journal:  J Contemp Brachytherapy       Date:  2020-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.